Drug Injury Watch

Side Effects News & Reports

From 2005 to the Present

All Articles by Tom Lamb

Tag: drug safety

Will Ocaliva Get Black-Box Warning For Liver Injury Side Effects After September 2017 FDA Report?

September 26, 2017

19 Patients Have Died While Using This New Liver Disease Drug, Some When Prescribed Higher-Than-Recommended Doses (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: “FDA adds Boxed Warning to highlight correct dosing of Ocaliva…
Continue reading…
Health Canada: There Is No Apparent Link Between Sovaldi Or Harvoni With Liver Cancer Recurrence As Of April 2017

June 1, 2017

Drug Regulatory Agency Has Requested Additional Safety Information From Some Manufacturers Of Direct-Acting Antivirals (DAAs) (Posted by Tom Lamb at DrugInjuryWatch.com) The May 2017 edition of Health Product InfoWatch included this report, “Summary…
Continue reading…
New MS Drug Ocrevus Gets Possible Bad News About Side Effects Soon After Good News About Sales Projections

May 25, 2017

Ocrevus – Progressive Multifocal Leukoencephalopathy (PML) Reported As Possible Side Effect In Germany, Says Drug Maker Roche (Posted by Tom Lamb at DrugInjuryWatch.com) In March 2017 the FDA approved Ocrevus (ocrelizumab injection)…
Continue reading…
May 2017 “Dear Doctor” Letter About Aranesp Cases Of Stevens-Johnson Syndrome (SJS) And Toxic Epidermal Necrolysis (TEN)

May 18, 2017

Current U.S. Version Of Full Prescribing Information Document For Aranesp Mentions Skin Rash Among Other Serious Allergic Reactions (Posted by Tom Lamb at DrugInjuryWatch.com) Aranesp (darbepoetin alfa) products for subcutaneous and intravenous…
Continue reading…
Farxiga MDL Created In April 2017; Assigned to Federal Court Judge Lorna Schofield In New York

May 12, 2017

This Consolidated Litigation Involves Farxiga And Xigduo XR; Side Effects Include Diabetic Ketoacidosis And Kidney Damage (Posted by Tom Lamb at DrugInjuryWatch.com) By means of this post, we are updating our March…
Continue reading…
Harvoni / Sovaldi: Spring 2017 Update On Issue Of Liver Cancer Recurrence After Using Direct-Acting Antiviral “Hep-C” Drugs

April 27, 2017

More Medical Studies Reach Different Conclusions About Whether New Hepatitis C Virus Medications Might Cause The Return Of Liver Cancer (Posted by Tom Lamb at DrugInjuryWatch.com) We continue to hear reports of patients…
Continue reading…
New Medical Evidence Suggests Pradaxa And Xarelto May Double The Risk Of Heart Attacks In Atrial Fibrillation Patients

April 12, 2017

An Observational Study Compared Myocardial Infarction / Heart Attack Risks As Between The Use Of Newer Blood Thinners And The Use Of Warfarin (Posted by Tom Lamb at DrugInjuryWatch.com) In the US,…
Continue reading…
Pradaxa Lawsuits And Settlements: Past, Present, And Future Aspects Are Explained In This 2017 Update Report

March 21, 2017

The Bottom Line: Pradaxa Is Still Associated With Serious Bleeding Events, Including Patient Deaths, And New Pradaxa Drug Injury Cases Are Still Being Filed (Posted by Tom Lamb at DrugInjuryWatch.com) Pradaxa (dabigatran)…
Continue reading…
February 2017 Label Changes For Sovaldi, Harvoni, And Other DAA Hepatitis C Drugs Are Made So As To Add A “Black-Box” Warning

February 16, 2017

Drug Safety Regulators Flag An Increased Risk Of Hepatitis B Virus Reactivation Which Can Result In Cases Of Fulminant Hepatitis, Liver Failure, And Death (Posted by Tom Lamb at DrugInjuryWatch.com) In February…
Continue reading…
Multiple Sclerosis Drug Tecfidera: FDA Mandates January 2017 Label Change Which Adds Warnings About Liver Injury Cases

February 7, 2017

Besides Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Renal Toxicity, And Other Safety Issues Have Surfaced Since Clinical Trials (Posted by Tom Lamb at DrugInjuryWatch.com) Tecfidera (dimethyl fumarate) was approved by the FDA in 2013…
Continue reading…